The Stop TB Partnership's Global Drug Facility Pediatric Drug-Resistant TB initiative

The Stop TB Partnership’s Global Drug Facility officially launched the Pediatric Drug-Resistant TB (DR-TB) Initiative aimed at ending the disease by increasing the access of child-friendly DR-TB treatments to children who need them, wherever they are in the world.

There is no official data on global pediatric DR-TB and estimates indicate that of the 1.1 million children under the age of 15 who became sick with TB in 2018 globally, an estimated 25,000 had DR-TB. Of those, fewer than 5% are diagnosed and received treatment. Even fewer of those under the age of five received treatment.

To read the full announcement, click here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By Stop TB Partnership

Published: Dec. 18, 2019, 1:19 p.m.

Last updated: Dec. 19, 2019, 2:24 p.m.

Print Share